Related Experiment Video
Updated: Jul 12, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates
K Garai1, B Sahoo, S K Kaushalya
1Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Colaba, Mumbai 400005, India.
Zinc ions (Zn2+) destabilize soluble amyloid-beta (Abeta) aggregates, which are implicated in Alzheimer's disease. This action reduces Abeta
Area of Science:
- Biochemistry
- Neuroscience
- Materials Science
Background:
- Soluble amyloid-beta (Abeta) aggregates are strongly implicated in the pathogenesis of Alzheimer's disease.
- The precise role and nature of these soluble aggregates, particularly their destabilization by metal ions, remain incompletely understood.
Purpose of the Study:
- To investigate the nature of soluble Abeta aggregates.
- To elucidate the mechanism by which Zn2+ destabilizes these aggregates.
- To determine the biological consequences of Zn2+ induced destabilization.
Main Methods:
- Analysis of Abeta aggregation kinetics in supersaturated solutions.
- Investigation of Zn2+ effects on Abeta aggregate size distribution.
- Assessment of neuronal toxicity of Abeta solutions.
Main Results:
- Larger soluble Abeta aggregates (>10 nm) form as intermediates in fibril formation from supersaturated solutions.
- Zn2+ destabilizes these intermediates by accelerating aggregation kinetics.
- The altered Abeta aggregate size distribution eliminates toxicity to cultured mammalian neurons.
Conclusions:
- Soluble Abeta aggregates are transient intermediates in fibril formation.
- Zn2+ acts by accelerating the aggregation kinetics of these intermediates, not by altering precipitation equilibrium.
- Zn2+ mediated destabilization of Abeta aggregates offers a potential therapeutic strategy for Alzheimer's disease by reducing neurotoxicity.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
10:01Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain
Published on: October 25, 2017
Related Concept Videos
EDTA: Auxiliary Complexing Reagents
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Antiprotozoal Agents